EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Case with Refractory Myasthenia Gravis Caused by Pembrolizumab

Bushra Amer, Fatima D Hawshab, Lateefah D Hawshab, Khaled M Darwesh

Journal of Community Hospital Internal Medicine Perspectives · 05.05.2025 · 15 (3) · 59-62

DOI: 10.55729/2000-9666.1486 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Community Hospital Internal Medicine Perspectives, online erschienen am 05.05.2025. Verfasst von Bushra Amer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Berkshire Medical Center, Pittsfield, MA, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nowadays, checkpoint inhibitors play a major role in the management of different types of cancers. However, we have seen variants of immune therapy-related adverse events, which usually are variables from fatigue, to neuropathy to severe devastating complications such as respiratory failure due to myasthenia gravis (MG), as we saw in our case. Our patient was started on pembrolizumab, and they developed severe respiratory failure attributed to MG after three weeks from treatment initiation. Also, the patient presented with myositis, mild myocarditis and hepatitis, which were all related to pembrolizumab.

Schlagwörter

Stichwörter der Autor:innen

CancerICIsMyasthenia gravisPembrolizumab

Autor:innen und Institutionen

  • Internal Medicine, Berkshire Medical Center, Pittsfield, MA, USA.
  • Gastroenterology and Hepatology, Sixth of October Hospital, Cairo, Egypt.
  • Gastroenterology and Hepatology, Ahmed Mahir Hospital, Cairo, Egypt.
  • Internal Medicine, Providence ST. Peter Hospital, Olympia, WA, USA.

Zitieren

APA

Amer, B., Hawshab, F. D., Hawshab, L. D., & Darwesh, K. M. (2025). Case with Refractory Myasthenia Gravis Caused by Pembrolizumab. Journal of Community Hospital Internal Medicine Perspectives, 15(3), 59-62. https://doi.org/10.55729/2000-9666.1486

Vancouver

Amer B, Hawshab FD, Hawshab LD, Darwesh KM. Case with Refractory Myasthenia Gravis Caused by Pembrolizumab. Journal of Community Hospital Internal Medicine Perspectives. 2025;15(3):59-62. doi:10.55729/2000-9666.1486

BibTeX
@article{Amer2025,
  author = {Amer, Bushra and Hawshab, Fatima D and Hawshab, Lateefah D and Darwesh, Khaled M},
  title = {Case with Refractory Myasthenia Gravis Caused by Pembrolizumab},
  journal = {Journal of Community Hospital Internal Medicine Perspectives},
  year = {2025},
  volume = {15},
  number = {3},
  pages = {59--62},
  doi = {10.55729/2000-9666.1486}
}
Kostenlos starten →